These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18221192)

  • 1. TRPV1 antagonists as a potential treatment for hyperalgesia.
    Roberts LA; Connor M
    Recent Pat CNS Drug Discov; 2006 Jan; 1(1):65-76. PubMed ID: 18221192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans.
    Chizh BA; O'Donnell MB; Napolitano A; Wang J; Brooke AC; Aylott MC; Bullman JN; Gray EJ; Lai RY; Williams PM; Appleby JM
    Pain; 2007 Nov; 132(1-2):132-41. PubMed ID: 17659837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
    Cui M; Honore P; Zhong C; Gauvin D; Mikusa J; Hernandez G; Chandran P; Gomtsyan A; Brown B; Bayburt EK; Marsh K; Bianchi B; McDonald H; Niforatos W; Neelands TR; Moreland RB; Decker MW; Lee CH; Sullivan JP; Faltynek CR
    J Neurosci; 2006 Sep; 26(37):9385-93. PubMed ID: 16971522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of transient receptor potential vanilloid 1 (TRPV1) receptor antagonist compounds SB705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing-temperature water bath.
    Tékus V; Bölcskei K; Kis-Varga A; Dézsi L; Szentirmay E; Visegrády A; Horváth C; Szolcsányi J; Petho G
    Eur J Pharmacol; 2010 Sep; 641(2-3):135-41. PubMed ID: 20534382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.
    Chakraborty S; Elvezio V; Kaczocha M; Rebecchi M; Puopolo M
    J Physiol; 2017 Apr; 595(8):2639-2660. PubMed ID: 28094445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia.
    Kanai Y; Hara T; Imai A; Sakakibara A
    J Pharm Pharmacol; 2007 May; 59(5):733-8. PubMed ID: 17524240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of TRPV channel block on polymodal activation of rat cutaneous nociceptors in vitro.
    St Pierre M; Reeh PW; Zimmermann K
    Exp Brain Res; 2009 Jun; 196(1):31-44. PubMed ID: 19404626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice.
    Watanabe M; Ueda T; Shibata Y; Kumamoto N; Ugawa S
    Neuroreport; 2015 Feb; 26(3):173-8. PubMed ID: 25590988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
    Blum CA; Caldwell T; Zheng X; Bakthavatchalam R; Capitosti S; Brielmann H; De Lombaert S; Kershaw MT; Matson D; Krause JE; Cortright D; Crandall M; Martin WJ; Murphy BA; Boyce S; Jones AB; Mason G; Rycroft W; Perrett H; Conley R; Burnaby-Davies N; Chenard BL; Hodgetts KJ
    J Med Chem; 2010 Apr; 53(8):3330-48. PubMed ID: 20307063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
    Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia.
    Planells-Cases R; Garcìa-Sanz N; Morenilla-Palao C; Ferrer-Montiel A
    Pflugers Arch; 2005 Oct; 451(1):151-9. PubMed ID: 15909179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drugs attenuate agonist-evoked activation of transient receptor potential channels.
    Tsagareli MG; Nozadze I; Tsiklauri N; Gurtskaia G
    Biomed Pharmacother; 2018 Jan; 97():745-751. PubMed ID: 29102918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain.
    Shinoda M; Ogino A; Ozaki N; Urano H; Hironaka K; Yasui M; Sugiura Y
    J Pain; 2008 Aug; 9(8):687-99. PubMed ID: 18455478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
    García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
    J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications.
    Cui M; Gosu V; Basith S; Hong S; Choi S
    Adv Protein Chem Struct Biol; 2016; 104():81-125. PubMed ID: 27038373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin receptor: TRPV1 a promiscuous TRP channel.
    Pingle SC; Matta JA; Ahern GP
    Handb Exp Pharmacol; 2007; (179):155-71. PubMed ID: 17217056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia.
    Kawamata T; Ji W; Yamamoto J; Niiyama Y; Furuse S; Namiki A
    Neuroscience; 2008 Jun; 154(3):1067-76. PubMed ID: 18495351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
    Sałat K; Filipek B
    J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Capsaicin receptor TRPV1].
    Tominaga M
    Brain Nerve; 2008 May; 60(5):493-501. PubMed ID: 18516971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.